70 -10 (60) 2023 — Mallaev M.M., Rakhmanov A.A. — ROLE OF MOLECULAR FEACHURES OF GASTRIC CANCER

ROLE OF MOLECULAR FEACHURES OF GASTRIC CANCER

Mallaev M.M.,  Tashkent Medical Academy

Rakhmanov A.A., Tashkent Medical Academy

Usmonov A.Sh.  Tashkent Medical Academy

Resume

 According to numerous studies. Today, many studies have confirmed that the risk potential of stomach cancer is related to its morphology and is widely used as one of the prognostic criteria for stomach cancer. At the same time, existing prognostic schemes are usually based on such characteristics as the degree of tumor differentiation, the depth of invasion, the type of growth, the degree of stroma formation and neo-angiogenesis, local immune responses.

Keywords: Gastric cancer, monoclonal antibodies, tumor morphology, checkpoint inhibitors

First page

412

Last page

421

For citation: Mallaev M.M.,  Rakhmanov A.A., Usmonov A.Sh. – ROLE OF MOLECULAR FEACHURES OF GASTRIC CANCER //New Day in Medicine 2023 10(60): 412-421 https://newdaymedicine.com/index.php/2023/10/18/l-473/

LIST OF REFERENCES:

  1. Haberman CR, Weiss F, Riecken R et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. // Radiology 230, 465–471 (2004).
  2. Hwang SW, Lee DH, Lee SH et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetectorrow omputed tomography. // J. Gastroenterol. Hepatol. 2010;25(3):512–518.
  3. Horton KM, Fishman EK. Current role of CT in imaging of the stomach. // Radiographics 23, 75–87 (2003). nn Good overview of multidetector CT technique and applications on gastric imaging.
  4. Gore RM. Upper gastrointestinal tract tumors: diagnosis and treating strategies. // Cancer Imaging 5, 95–98 (2005).
  5. Kim HJ, Kim AY, Oh ST et al. Gastric cancer staging at multi-detector row CT gastrography: comparison of transverse and volumetric CT scanning. // Radiology 236, 879–885 (2005).
  6. Sarela AI, Miner TJ, Karpeh MS et al. Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. // Ann. Surg. 243, 189–195 (2006).
  7. Kim EY, Lee WJ, Choi D et al. The value of PET-CT for preoperative staging of advanced gastric cancer: comparison with contrastenhanced CT. // Eur. J. Radiol. 79, 183–188 (2011). nn One of the earliest papers on the use of PET/CT for preoperative staging of gastriccancer and in comparison to multidetector CT.
  8. Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom. // Imaging 34, 441–447 (2009). nn One of the early few studies on PET/CT in patients with suspected recurrent gastric cancer with a high positive predictive value.
  9. Nakamoto Y, Togashi K, Kaneta T et al. Clinical value of whole body PET for recurrent gastric cancer: a multicenter study. // Jap. J. Clin. Oncol. 39(5), 297–302 (2009). nn Multicenter study on clinical usefulness of 18F-fluorodeoxyglucose‑PET in patients with suspected recurrent gastric cancer, demonstrating change in therapeutic management in up to 48% of the patients in a selected patient group.
  10. Sun L, Su XH, Guan YS et al. Clinical role of 18F fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. // World J. Gastroenterol. 14(29), 4627–4632 (2008).
  11. Potter TD, Flamen P, Cutsem V et al. Whole body PET with FDG for the diagnosis of nrecurrent gastric cancer. // Eur. J. Nucl. Med. 29(4), 525–529 (2002).
  12. Stahl A, Ott K, Weber WA et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. // Eur. J. Nucl. Med. 30(2), 288–295 (2003).
  13. Salaun PY, Grewal RK, Dodamane I et al. An analysis of the 18F-FDG uptake pattern in the stomach. // J. Nucl. Med. 46, 48–51 (2005).
  14. Koga H, Sasaki M, Kuwabara Y et al. An analysis of the physiological FDG uptake pattern in the stomach. // Ann. Nucl. Med. 17(8), 733–738 (2003).
  15. Kamimura K, Fujita S, Nishii R et al. An analysis of physiological FDG uptake in the stomach with the water gastric distention method. // Eur. J. Nucl. Med. Mol. Imaging 34, 1815–1818 (2007).
  16. Imperiale A, Cimarelli S, Sellem DB, Blondet C, Contantinesco A. Focal F-18 FDG uptake mimicking malignant gastric localizations disappearing after water ingestion on PET/CT images. // Clin. Nucl. Med. 31(12), 835–837 (2006).
  17. Tian J, Chen L, Wei B et al. The value of vesicant 18F‑FDG PET in gastric malignancies. // Nucl. Med. Commun. 25, 825–831 (2004).
  18. Kamimura K, Nagamachi S, Wakamatsu H et al. Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-dglucose PET. // Nucl. Med. Commun. 30, 431–439 (2009).
  19. Yun M, Choi HS, Yoo E, Bong JK, Ryu YH, Lee JD. The role of gastric distention in differentiating recurrent tumor from physiological uptake in the remnant stomach on 18F‑FDG PET. // J. Nucl. Med. 46, 953–957 (2005).
  20. Chen J, Cheong JH, Yun MJ et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. // Cancer 103, 2383–2390 (2005).



file

download